Editor's Picks: Could weight-loss drugs eat the world?

编辑精选:减肥药物能否吞噬全球?

Editor's Picks from The Economist

新闻

2024-04-09

14 分钟
PDF

单集简介 ...

A handpicked article read aloud from the latest issue of The Economist. Today, a new generation of weight-loss drugs has taken the world by storm. We explore the other diseases that may be helped by the medicines. Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+
更多

单集文稿 ...

  • The Economist Hello, it's Alok Jha here.

  • I host Babbage, our weekly podcast on science and technology.

  • Welcome to Editors' Picks.

  • You're about to hear an article from the latest edition of The Economist.

  • Enjoy.

  • The Gila monster is a poisonous North American lizard that measures around 50 centimeters and sports a distinctive coat of black and orange scales.

  • This lethargic reptile,

  • which mostly dwells underground and eats just three to four times a year,

  • is the unlikely inspiration for one of farmers biggest blockbusters.

  • a new generation of weight loss drugs that has patients and investors in a frenzy.

  • Originally made for diabetes,

  • evidence is growing that they also have benefits in diseases of the heart,

  • kidney, liver and beyond.

  • Since the late 1980s,

  • scientists believed that a gut hormone called glucagon-like peptide 1,

  • or GLP-1, which is secreted by the intestines after a meal, could help treat diabetes.

  • GLP-1 increases the production of insulin, a hormone that lowers blood sugar levels,

  • and reduces the production of glucagon, which increases blood sugar levels.

  • But GLP-1 is broken down by enzymes in the body very quickly,

  • so it sticks around for only a few minutes.